Towards a vaccine against Plasmodium vivax malaria
- PMID: 18092888
- PMCID: PMC2140083
- DOI: 10.1371/journal.pmed.0040350
Towards a vaccine against Plasmodium vivax malaria
Abstract
The authors discuss a new study that suggests thatPlasmodium vivax Duffy-binding protein could be a candidate antigen for developing aP. vivax vaccine.
Conflict of interest statement
Figures

Comment on
-
Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein.PLoS Med. 2007 Dec;4(12):e337. doi: 10.1371/journal.pmed.0040337. PLoS Med. 2007. PMID: 18092885 Free PMC article.
References
-
- Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg. 2001;64(1–2 Suppl):97–106. - PubMed
-
- Grimberg BT, Udomsangpetch R, Xainli J, McHenry A, Panichakul T, et al. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the duffy binding protein. PLoS Med. 2007;4:e337. doi: 10.1371/journal.pmed.0040337. - DOI - PMC - PubMed
-
- Adams JH, Hudson DE, Torii M, Ward GE, Wellems TE, et al. The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites. Cell. 1990;63:141–153. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources